Search research articles
Contact Us
Filters
Showing results (1-10 of 196) with videos related to
Page
of 20
Sort By:
Nature
|
September 3, 2011
Cancer: Tumour-fighting virus homes in
Evanthia Galanis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2026
Integrated Molecular Diagnosis Paving the Way for Therapeutic Success in Recurrent Astrocytoma Treatment
Evanthia Galanis
The New England Journal of Medicine
|
June 29, 2022
Virotherapy for Brain Tumors - Defining the Path to Success
Evanthia Galanis
Current Opinion in Molecular Therapeutics
|
March 9, 2002
Technology evaluation: Allovectin-7, Vical
Evanthia Galanis
Oncology (Williston Park, N.Y.)
|
December 17, 2014
Tailoring chemotherapy for low-grade gliomas
Evanthia Galanis
Nature Reviews. Clinical Oncology
|
July 29, 2009
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
Axel Grothey, Evanthia Galanis
Expert Opinion on Biological Therapy
|
January 29, 2017
Potential and clinical translation of oncolytic measles viruses
Steven Robinson, Evanthia Galanis
Expert Review of Anticancer Therapy
|
December 1, 2006
Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates
Lijo Simpson, Evanthia Galanis
Oncotarget
|
March 23, 2019
Interferon signaling predicts response to oncolytic virotherapy
Cheyne Kurokawa, Evanthia Galanis
Molecular Oncology
|
August 11, 2016
MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors
Hirosha Geekiyanage, Evanthia Galanis
Page
of 20
Search research articles
Search
Showing results (1-10 of 196) with videos related to
Sort By:
Page
of 20
Nature
|
September 3, 2011
Cancer: Tumour-fighting virus homes in
Evanthia Galanis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2026
Integrated Molecular Diagnosis Paving the Way for Therapeutic Success in Recurrent Astrocytoma Treatment
Evanthia Galanis
The New England Journal of Medicine
|
June 29, 2022
Virotherapy for Brain Tumors - Defining the Path to Success
Evanthia Galanis
Current Opinion in Molecular Therapeutics
|
March 9, 2002
Technology evaluation: Allovectin-7, Vical
Evanthia Galanis
Oncology (Williston Park, N.Y.)
|
December 17, 2014
Tailoring chemotherapy for low-grade gliomas
Evanthia Galanis
Nature Reviews. Clinical Oncology
|
July 29, 2009
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
Axel Grothey, Evanthia Galanis
Expert Opinion on Biological Therapy
|
January 29, 2017
Potential and clinical translation of oncolytic measles viruses
Steven Robinson, Evanthia Galanis
Expert Review of Anticancer Therapy
|
December 1, 2006
Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates
Lijo Simpson, Evanthia Galanis
Oncotarget
|
March 23, 2019
Interferon signaling predicts response to oncolytic virotherapy
Cheyne Kurokawa, Evanthia Galanis
Molecular Oncology
|
August 11, 2016
MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors
Hirosha Geekiyanage, Evanthia Galanis
Page
of 20